维普期刊资源整合服务平台（V6.5）

350篇 您的检索式：作者名="Twelves"

选中清除导出查看参考文献查看引证文献引用追踪共18页首页上一页第1页下一页末页 /18 跳转

	题名	作者	年代	出处	被引量
1	Pronmositic factors in women with breast cancer:distribution by socioeconomic status and effect on differences in survival显示文摘	Thomson CS Hole DJ Twelves CJ	2001	J Epidemilo Community Health2001，55，5：	2
2	Capecitabine as adjuvant treatment for stage Ⅲ colon cancer显示文摘	TWELVES C WONG A NOWACKI M P	2005	N Engl J Med2005，352，26：	1
3	Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites显示文摘	Twelves C Glynne-Jones R Cassidy J	1999	Clin Cancer Res1999，5，7：	1
4	XELOX (capecitabine plus oxaliplatin):active first-line therapy for patients with metastatic colorectal cancer显示文摘	Cassidy J Tabernero J Twelves C	2004	J Clin Oncol2004，22，11：	1
5	XELOX (Capecitabine Plus Oxaliplatin):Active First-Line Therapy for Patients With Metastatic Colorectal Cancer显示文摘	Cassidy J Tabernero J Twelves C	2004	J Clin Oncol2004，22，11：	1
6	Acute reversible neurological deficit following intrathecal chemotherapy显示文摘	Dunkelman H Earl HM Twelves C	1991	Cancer Chemother Pharmacol1991，27，4：	1
7	Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients 显示文摘	Poole C Gardiner J Twelves C	2002	Cancer Chemother Pharmacol2002，49，3：	1
8	Can capecitabine replace 5-FU/leucovorin in c- ombination with oxaliplatin for the treatment of advanced- colorectal cancer显示文摘	Twelves C	2002	Oncology2002，16，1214：	1
9	Xel ox(Capecitabine Plus Oxaliplatin):Active First -Line Therapy for Patients With Metastatic Colorectal Cancer显示文摘	Cassidy J Tabernero J Twelves C		0，，11：	1
10	Efficacy of eribu-lin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies显示文摘	Twelves C Cortes J Vahdat L	2014	Breast Cancer Res Treat2014，148，3：	1
11	Phase I and pharmacokinetic study of Yondelis(TM)(Ecteinascidin-743;ET-743)administered as an infusion over 1 h or3h every 21 days in patients with solid tumours显示文摘	Twelves C Hoekman K Bowman A	2003	European Journal of Cancer2003，39，13：	1
12	Xelox( capecitabine plus oxaliplatin) :active first-line therapy for patients with metastatic color- ectal cancer 显示文摘	Cassidy J Tabernero J Twelves C	2004	J Clin Onco12004，22，11：	1
13	Protein kinase C:a target for anticancer drugs? 显示文摘	Mackay HJ Twelves CJ	2003	Endocr Relat Cancer2003，10，3：	1
14	Capecitabine as adjuvant treatment for stage Ⅲ colon cancer显示文摘	Twelves C Wong A Nowacki MP		0，，：	1
15	A phase I study of ZD0473 combined with paclitaxel for the treatment of solid malignancies显示文摘	Chris Twelves Martin Reck Alan Anthoney Ulrich Gatzemeier Stan Kaye	2003	Cancer Chemotherapy and Pharmacology2003，，4：	1
16	Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients metastatic colorectal cancer:post hoc analysis of a large phase 1I study显示文摘	Twelves CJ Butts CA Cassidy J	2005	Clin Colorectal Cancer2005，5，2：	1
17	Phase Ⅰ and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer显示文摘	Mackean M Planting A Twelves C	1998	J Clin Oncol1998，16，9：	1
18	Mammary ducto- scopy in the current management of breast disease 显示文摘	TANG S S TWELVES D J ISACKE C M	2011	Surg En- dosc2011，25，6：	1
19	XELOX (capecit- abine plus oxaliplatin) : active first-line therapy for patients with metastatic colorectal cancer 显示文摘	Cassidy J Tabernero J Twelves C	2004	J Clin Oncol2004，22，11：	1
20	Mammary ducto- scopy in the current management of breast disease 显示文摘	TANG S S TWELVES D J ISACKE C M	2011	Surg En- dosc2011，25，6：	1

返回顶部每页显示：

共18页首页上一页第1页下一页末页 /18 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示